Results 21 to 30 of about 6,506,258 (188)

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment

open access: yesHaematologica, 2018
Mantle cell lymphoma and other lymphoma subtypes often spread to the bone marrow, and stromal interactions mediated by focal adhesion kinase frequently enhance survival and drug resistance of the lymphoma cells. To study the role of focal adhesion kinase
Martina Rudelius   +7 more
doaj   +1 more source

Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma

open access: yesHaematologica, 2011
Background Type I insulin-like growth factor receptor (IGF-IR) tyrosine kinase induces significant oncogenic effects. Strategies to block IGF-IR signaling are being tested in clinical trials that include patients with aggressive solid malignancies ...
Deeksha Vishwamitra   +6 more
doaj   +1 more source

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

open access: yesHaematologica, 2010
Background The deregulation of several transcription factors contribute to the aggressive course of mantle cell lymphoma. This study focuses on survival signals emanating from the tumor environment and involving the signal transducer and activator of ...
Fanny Baran-Marszak   +10 more
doaj   +1 more source

Skin manifestation of mantle cell lymphoma – case report and literature review [PDF]

open access: yes, 2017
Mantle cell lymphoma is a rare neoplastic disease of the lymphatic system derived from mature B lymphocytes. It very commonly affects extranodal sites including the bone marrow, gastrointestinal tract and Waldeyer’s ring, but skin involvement is seen ...
Natalia Zdanowska   +5 more
core   +1 more source

Precision Matters: Minor Concentration Deviations of DMSO May Cause Major Efficacy Shifts

open access: yesAngewandte Chemie, EarlyView.
Low‐concentration dimethyl sulfoxide (DMSO) has long been regarded as biologically safe in drug discovery. However, increasing DMSO from 0.1% to 0.9% reduces photosensitizer PNA‐9 particle size from 657 nm to 260 nm, enhancing endocytosis and photodynamic therapy outcomes.
Sisi Yuan   +6 more
wiley   +2 more sources

Magnetic resonance imaging with pathological correlation in a case of mantle cell lymphoma of the parotid gland: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Mantle cell lymphoma is a rare non-Hodgkin's lymphoma. It is a subtype of B-cell lymphoma with frequent involvement of the bone marrow and the gastrointestinal tract. Isolated parotid gland involvement seldom occurs.
Karakozoglou Thrasivulos   +4 more
doaj   +1 more source

A Rare Case of Severe Lactic Acidosis in a Patient With Mantle Cell Lymphoma

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2021
Lactic acidosis is an extremely rare paraneoplastic manifestation of hematological malignancies, and often carries an extremely poor prognosis. Mantle cell lymphoma is an aggressive and rare form of non-Hodgkin lymphoma.
Kok Hoe Chan MD   +5 more
doaj   +1 more source

Acalabrutinib for mantle cell lymphoma [PDF]

open access: yesBlood, 2019
AbstractMantle cell lymphoma (MCL) is a unique type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1. MCL patients typically live for years but experience multiple relapses. Acalabrutinib is a novel second-generation oral Bruton tyrosine kinase inhibitor approved by the US Food and Drug Administration for relapsed MCL based on a
David Inwards, Thomas E. Witzig
openaire   +2 more sources

Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR

open access: yesHaematologica, 2009
Mantle cell lymphoma is characterized by the t(11;14) chromosomal translocation, resulting in the overexpression of cyclin D1 (CycD1). Recently, cases of mantle cell lymphoma negative for cycD1 but positive for cycD2 or cycD3 were identified by gene ...
Leticia Quintanilla-Martinez   +9 more
doaj   +1 more source

DO DIAGNÓSTICO DIFERENCIAL ÀS COMPLICAÇÕES INFECCIOSAS: UM CASO INCOMUM DE LINFOMA DE CÉLULAS DO MANTO - RELATO DE CASO

open access: yesHematology, Transfusion and Cell Therapy
Introdução: O linfoma de células do manto (LCM) é uma neoplasia linfoide B agressiva, caracterizada habitualmente por acometimento linfonodal, esplênico, medular e/ou extranodal.
Caio César DE LIMA SILVA   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy